Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma

NCT02701673 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Busulfan
DRUG: Caphosol
DRUG: Glutamine
DRUG: Pyridoxine
DRUG: Belinostat
DRUG: Azacitidine
DRUG: Gemcitabine
DRUG: Melphalan
PROCEDURE: Stem Cell Transplant

Sponsor

M.D. Anderson Cancer Center